about
Epigenetic changes in the myelodysplastic syndrome.Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"?Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes.Infliximab chimeric antitumor necrosis factor-a monoclonal antibody as potential treatment for myelodysplastic syndromes.Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome.AML1/RUNX1 works as a negative regulator of c-Mpl in hematopoietic stem cells.Diagnostic challenges in the myelodysplastic syndromes: the current and future role of genetic and immunophenotypic studies.Azacitidine for myelodysplastic patients aged > 65 years: a review of clinical efficacy.Annotating Function to Differentially Expressed LincRNAs in Myelodysplastic Syndrome Using a Network-Based Method.Prognostic Significance of NRAS Gene Mutations in Children with Acute Myelogenous Leukemia.Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.Molecular cloning of t(2;7)(p24.3;p14.2), a novel chromosomal translocation in myelodysplastic syndrome-derived acute myeloid leukemia.Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome.C-terminal mutation of RUNX1 attenuates the DNA-damage repair response in hematopoietic stem cells.
P2860
Q33767309-FB4F694F-8923-4084-B3C3-A00673B96795Q35001132-CFA13194-998A-4B42-BEF9-4FCE72655E20Q35214418-AEA21FA7-5561-4B0E-9994-5474635DA083Q36194610-1C20BFD3-A74F-4419-B1CA-E46E21B9ADCDQ36477407-B9388403-B4F5-48A6-A09A-614187D2DCC4Q37142554-1874EEF3-63CB-4D21-B89A-74A9C192543FQ38089064-BF46A55F-F206-485A-8883-9AFA1D1A3608Q38225750-2E5DC691-4BF5-4AF1-94D2-29011725489FQ38804181-9A6B6BD7-E9A6-40B4-B14E-C2562AE914FCQ40055219-2CA22CA8-B0A2-4DB3-93FF-2831DFE29BFCQ40318729-6EA49F4C-F3A8-47C4-9961-F65DEF233114Q46901611-FA8EC182-8AD2-4A5B-A5D8-725F1B032173Q47387653-7F1563A2-1E1A-4A37-A608-152B066019ACQ53226362-24406693-9254-49B2-8EAB-9147DFE502FA
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Molecular mechanisms of myelodysplastic syndrome.
@ast
Molecular mechanisms of myelodysplastic syndrome.
@en
Molecular mechanisms of myelodysplastic syndrome.
@nl
type
label
Molecular mechanisms of myelodysplastic syndrome.
@ast
Molecular mechanisms of myelodysplastic syndrome.
@en
Molecular mechanisms of myelodysplastic syndrome.
@nl
prefLabel
Molecular mechanisms of myelodysplastic syndrome.
@ast
Molecular mechanisms of myelodysplastic syndrome.
@en
Molecular mechanisms of myelodysplastic syndrome.
@nl
P356
P1476
Molecular mechanisms of myelodysplastic syndrome.
@en
P2093
Hisamaru Hirai
P304
P356
10.1093/JJCO/HYG037
P577
2003-04-01T00:00:00Z